FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024582127> ?p ?o ?g. }

• W2024582127 endingPage "e108263" @default.
• W2024582127 startingPage "e108263" @default.
• W2024582127 abstract "Objective To evaluate the association between androstenedione, testosterone, and free testosterone and metabolic disturbances in polycystic ovary syndrome. Methods We analyzed the association between androstenedione, testosterone, and free testosterone and metabolic parameters in a cross-sectional study including 706 polycystic ovary syndrome and 140 BMI-matched healthy women. Polycystic ovary syndrome women were categorized into 4 groups: normal androstenedione and normal free testosterone (NA/NFT), elevated androstenedione and normal free testosterone (HA/NFT), normal androstenedione and elevated free testosterone (NA/HFT), elevated androstenedione and free testosterone (HA/HFT). Results Polycystic ovary syndrome women with elevated free testosterone levels (HA/HFT and NA/HFT) have an adverse metabolic profile including 2 h glucose, HbA1c, fasting and 2 h insulin, area under the insulin response curve, insulin resistance, insulin sensitivity index (Matsuda), triglycerides, total and high density lipoprotein cholesterol levels compared to NA/NFT (p<0.05 for all age- and BMI-adjusted analyses). In binary logistic regression analysis adjusted for age and BMI, odds ratio for insulin resistance was 2.78 (1.34–5.75, p = 0.006) for polycystic ovary syndrome women with HA/HFT compared to NA/NFT. We found no significantly increased risk of metabolic disorders in polycystic ovary syndrome women with HA/NFT. In multiple linear regression analyses (age- and BMI-adjusted), we found a significant negative association between androstenedione/free testosterone-ratio and area under the insulin response curve, insulin resistance, and total cholesterol/high density lipoprotein cholesterol-ratio and a positive association with Matsuda-index, and high density lipoprotein cholesterol (p<0.05 for all). Conclusions Polycystic ovary syndrome women with elevated free testosterone levels but not with isolated androstenedione elevation have an adverse metabolic phenotype. Further, a higher androstenedione/free testosterone-ratio was independently associated with a beneficial metabolic profile." @default.
• W2024582127 created "2016-06-24" @default.
• W2024582127 creator A5005287881 @default.
• W2024582127 creator A5008241562 @default.
• W2024582127 creator A5043082129 @default.
• W2024582127 creator A5085253505 @default.
• W2024582127 creator A5089833535 @default.
• W2024582127 date "2014-10-13" @default.
• W2024582127 modified "2023-10-18" @default.
• W2024582127 title "Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype" @default.
• W2024582127 cites W1600739567 @default.
• W2024582127 cites W1806371349 @default.
• W2024582127 cites W1969092794 @default.
• W2024582127 cites W1973003140 @default.
• W2024582127 cites W1975453845 @default.
• W2024582127 cites W1979253761 @default.
• W2024582127 cites W1984067141 @default.
• W2024582127 cites W2007030055 @default.
• W2024582127 cites W2026929955 @default.
• W2024582127 cites W2040874437 @default.
• W2024582127 cites W2088778349 @default.
• W2024582127 cites W2095645359 @default.
• W2024582127 cites W2099162991 @default.
• W2024582127 cites W2100306033 @default.
• W2024582127 cites W2100691602 @default.
• W2024582127 cites W2103099714 @default.
• W2024582127 cites W2104748844 @default.
• W2024582127 cites W2105749473 @default.
• W2024582127 cites W2106226862 @default.
• W2024582127 cites W2109234158 @default.
• W2024582127 cites W2120973019 @default.
• W2024582127 cites W2126327417 @default.
• W2024582127 cites W2128981238 @default.
• W2024582127 cites W2132186367 @default.
• W2024582127 cites W2133795831 @default.
• W2024582127 cites W2134114387 @default.
• W2024582127 cites W2137710668 @default.
• W2024582127 cites W2144728016 @default.
• W2024582127 cites W2151465923 @default.
• W2024582127 cites W2159027107 @default.
• W2024582127 cites W2161221983 @default.
• W2024582127 cites W2161330749 @default.
• W2024582127 cites W2167058441 @default.
• W2024582127 cites W2169585002 @default.
• W2024582127 cites W2171845459 @default.
• W2024582127 cites W2172288279 @default.
• W2024582127 cites W2510708214 @default.
• W2024582127 cites W4256605237 @default.
• W2024582127 doi "https://doi.org/10.1371/journal.pone.0108263" @default.
• W2024582127 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4195601" @default.
• W2024582127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25310562" @default.
• W2024582127 hasPublicationYear "2014" @default.
• W2024582127 type Work @default.
• W2024582127 sameAs 2024582127 @default.
• W2024582127 citedByCount "77" @default.
• W2024582127 countsByYear W20245821272015 @default.
• W2024582127 countsByYear W20245821272016 @default.
• W2024582127 countsByYear W20245821272017 @default.
• W2024582127 countsByYear W20245821272018 @default.
• W2024582127 countsByYear W20245821272019 @default.
• W2024582127 countsByYear W20245821272020 @default.
• W2024582127 countsByYear W20245821272021 @default.
• W2024582127 countsByYear W20245821272022 @default.
• W2024582127 countsByYear W20245821272023 @default.
• W2024582127 crossrefType "journal-article" @default.
• W2024582127 hasAuthorship W2024582127A5005287881 @default.
• W2024582127 hasAuthorship W2024582127A5008241562 @default.
• W2024582127 hasAuthorship W2024582127A5043082129 @default.
• W2024582127 hasAuthorship W2024582127A5085253505 @default.
• W2024582127 hasAuthorship W2024582127A5089833535 @default.
• W2024582127 hasBestOaLocation W20245821271 @default.
• W2024582127 hasConcept C126322002 @default.
• W2024582127 hasConcept C134018914 @default.
• W2024582127 hasConcept C2776683971 @default.
• W2024582127 hasConcept C2777391703 @default.
• W2024582127 hasConcept C2777911890 @default.
• W2024582127 hasConcept C2779279991 @default.
• W2024582127 hasConcept C2779306644 @default.
• W2024582127 hasConcept C2780578515 @default.
• W2024582127 hasConcept C3018442814 @default.
• W2024582127 hasConcept C511355011 @default.
• W2024582127 hasConcept C71315377 @default.
• W2024582127 hasConcept C71924100 @default.
• W2024582127 hasConcept C86803240 @default.
• W2024582127 hasConceptScore W2024582127C126322002 @default.
• W2024582127 hasConceptScore W2024582127C134018914 @default.
• W2024582127 hasConceptScore W2024582127C2776683971 @default.
• W2024582127 hasConceptScore W2024582127C2777391703 @default.
• W2024582127 hasConceptScore W2024582127C2777911890 @default.
• W2024582127 hasConceptScore W2024582127C2779279991 @default.
• W2024582127 hasConceptScore W2024582127C2779306644 @default.
• W2024582127 hasConceptScore W2024582127C2780578515 @default.
• W2024582127 hasConceptScore W2024582127C3018442814 @default.
• W2024582127 hasConceptScore W2024582127C511355011 @default.
• W2024582127 hasConceptScore W2024582127C71315377 @default.
• W2024582127 hasConceptScore W2024582127C71924100 @default.
• W2024582127 hasConceptScore W2024582127C86803240 @default.
• W2024582127 hasIssue "10" @default.

• next